STABILIZED FORMULATION COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN
Application
US20260083671A1
Kind: A1
Mar 26, 2026
Inventors
David SONG
Abstract
The present invention relates to a stabilized pharmaceutical formulation comprising a recombinant stabilized galectin-9 protein. More specifically, the invention provides a pharmaceutical formulation with improved stability through the combination of a buffer and a stabilizer.
CPC Classifications
A61K 9/08
A61K 9/19
A61K 38/1732
A61K 47/02
A61K 47/12
A61K 47/183
A61K 47/22
A61K 47/26
Filing Date
2025-08-08
Application No.
19295090